In October 2016 in Vienna, Austria, Shire organised and attended the sixth European Symposium on Lysosomal Storage Disorders (or the ESLSD for short).
This global event brought together 28 faculties and over 350 delegates from 31 different countries. Everyone who attended was taken on an amazing ‘guided journey’ from cell biology through to the latest therapy in lysosomal storage disorders (LSDs). Here are the highlights for you.
LSDs are inherited metabolic diseases caused by enzyme deficiencies and are characterised by an abnormal build-up of toxic waste cells. Hunter syndrome, Fabry and Gaucher disease are all categorised as LSDs.1
To begin the day, Dr Tom Alan Fowler and Dr Derralynn Hughes took to the stage. Their presentation focused on a new venture called the ‘100,000 Genomes Project’ and its important contribution to improving the diagnosis of rare diseases.
There were then nine ‘Meet the Experts’ sessions designed to give smaller groups the chance to discuss challenges from within their own practices, along with the finer details of Fabry, Gaucher and Hunter syndrome.
These mini sessions were extremely well attended and proved to be a refreshing addition to the more formal, scientific agenda. The experts’ enthusiasm and their desire to interact with attendees in this more informal way made the sessions really productive.
We’re proud to say the sixth ESLSD was a huge success with attendees reporting the event had been lifted ‘to another level’. By hosting a focused, expert environment that inspired interactivity, the organisers created a vital exchange of information that will go on to make a real difference to patients’ lives.
The seventh ESLSD is just around the corner. We’ll tell you more about it nearer the time so keep checking back or sign up to the newsletter to get the latest news emailed to you.
Everyone living with a rare disease has a story to tell. Whether it affects you directly or you’re a friend, colleague, family member or healthcare professional, we all have our own challenges and ways with dealing with them.